These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26292454)

  • 1. Evolution of Growth Hormone Devices: Matching Devices with Patients.
    Raimer-Hall D; Shea HC
    Pediatr Nurs; 2015; 41(2):72-7. PubMed ID: 26292454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone delivery devices: current features and potential for enhanced treatment adherence.
    Rohrer TR; Horikawa R; Kappelgaard AM
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1253-1264. PubMed ID: 27718757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patients.
    Pfützner A; Hartmann K; Winter F; Fuchs GS; Kappelgaard AM; Rohrer TR
    Clin Ther; 2010 Oct; 32(11):1918-34. PubMed ID: 21095487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients.
    Kappelgaard AM; Mikkelsen S; Knudsen TK; Fuchs GS
    J Pediatr Endocrinol Metab; 2011; 24(7-8):489-96. PubMed ID: 21932587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay.
    Meinhardt U; Eiholzer U; Seitz L; Bøgelund M; Kappelgaard AM
    Expert Rev Med Devices; 2014 Jan; 11(1):31-8. PubMed ID: 24308742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to growth hormone therapy in children and its potential barriers.
    Mohseni S; Heydari Z; Qorbani M; Radfar M
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):13-20. PubMed ID: 29216008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel long-acting GH preparations.
    Doknic M; Stojanovic M; Popovic V
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):206-12. PubMed ID: 25581986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children.
    Haverkamp F; Gasteyger C
    J Med Econ; 2011; 14(4):448-57. PubMed ID: 21651428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving adherence to GH therapy with an electronic device: first experience with easypod.
    Kirk J
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():549-52. PubMed ID: 19550392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of injection dose force, accuracy and precision among three growth hormone injection devices.
    Kappelgaard AM; Hansen NÅ
    Expert Rev Med Devices; 2013 May; 10(3):321-7. PubMed ID: 23560872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid growth hormone: preservatives and buffers.
    Kappelgaard AM; Bojesen A; Skydsgaard K; Sjögren I; Laursen T
    Horm Res; 2004; 62 Suppl 3():98-103. PubMed ID: 15539807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth.
    Desrosiers P; O'Brien F; Blethen S
    Pediatr Endocrinol Rev; 2005 Feb; 2 Suppl 3():327-31. PubMed ID: 16456500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone therapy with norditropin ( somatropin ) in growth hormone deficiency.
    Pawlikowska-Haddal A
    Expert Opin Biol Ther; 2013 Jun; 13(6):927-32. PubMed ID: 23662811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for recombinant human growth hormone and evaluation of available recombinant human growth hormone devices: implications for managed care organizations.
    Dunn JD; Nickman NA
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS16-22. PubMed ID: 22590764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens.
    Rohrer TR; Winter F; Qvist M; Kappelgaard AM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1603-12. PubMed ID: 24073645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining patient choice of device for GH therapy.
    Wickramasuriya BP; Casey A; Akhtar S; Zia R; Ehtisham S; Barrett TG; Shaw NJ; Kirk JM
    Horm Res; 2006; 65(1):18-22. PubMed ID: 16357486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children and adolescent acceptability of a new device system to administer human growth hormone--a pilot study.
    Kappelgaard AM; Mikkelsen S; Bagger C; Fuchs GS
    J Pediatr Endocrinol Metab; 2012; 25(3-4):285-94. PubMed ID: 22768658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review.
    Antalfy A; Berman K; Everitt C; Alten R; Latymer M; Godfrey CM
    Adv Ther; 2023 Nov; 40(11):4758-4776. PubMed ID: 37733212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.